These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12145704)

  • 1. Sequence conservation of RAG-1 and RAG-2 genes in hematologic malignancies.
    Mulero MC; Estivill C; Corral J; Sierra J; Baiget M; Nomdedéu JF
    Leukemia; 2002 Aug; 16(8):1571. PubMed ID: 12145704
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatic mutation of CYLD gene is rare in hematologic and solid malignancies.
    Kim MS; Chung NG; Yoo NJ; Lee SH
    Leuk Res; 2011 Jul; 35(7):e136-7. PubMed ID: 21420166
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutations and aberrant DNA methylation of the PROX1 gene in hematologic malignancies.
    Nagai H; Li Y; Hatano S; Toshihito O; Yuge M; Ito E; Utsumi M; Saito H; Kinoshita T
    Genes Chromosomes Cancer; 2003 Sep; 38(1):13-21. PubMed ID: 12874782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal diagnosis of RAG-deficient Omenn syndrome.
    Villa A; Bozzi F; Sobacchi C; Strina D; Fasth A; Pasic S; Notarangelo LD; Vezzoni P
    Prenat Diagn; 2000 Jan; 20(1):56-9. PubMed ID: 10701853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis.
    Faber C; Morbach H; Singh SK; Girschick HJ
    Ann Rheum Dis; 2006 Oct; 65(10):1351-6. PubMed ID: 16504994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCR transfer induces TCR-mediated tonic inhibition of RAG genes in human T cells.
    Orlando L; Accomasso L; Circosta P; Turinetto V; Lantelme E; Porcedda P; Minieri V; Pautasso M; Willemsen RA; Cignetti A; Giachino C
    Mol Immunol; 2011 Jul; 48(12-13):1369-76. PubMed ID: 21481940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL-6 in diffuse large-cell lymphomas.
    Dalla-Favera R; Ye BH; Cattoretti G; Lo Coco F; Chang CC; Zhang J; Migliazza A; Cechova K; Niu H; Chaganti S; Chen W; Louie DC; Offit K; Chaganti RS
    Important Adv Oncol; 1996; ():139-48. PubMed ID: 8791133
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of testicular genes in haematological malignancies.
    Lim SH; Austin S; Owen-Jones E; Robinson L
    Br J Cancer; 1999 Dec; 81(7):1162-4. PubMed ID: 10584877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of allele-specific quantitative PCR using genomic DNA to monitor minimal residual disease based on mutant gene levels following allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies: comparison of mutant levels with autologous DNA percentage by short tandem repeat-PCR.
    Taira C; Matsuda K; Saito S; Sakashita K; Sugano M; Okumura N; Honda T
    Clin Chim Acta; 2012 Feb; 413(3-4):516-9. PubMed ID: 22138486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of RAG-1 in lymphoid malignancies.
    Nomdedéu J; Lasa A; Seminago R; Mateu R; Rubiol E; Baiget M; Soler J
    Leukemia; 1996 Nov; 10(11):1715-8. PubMed ID: 8892673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer.
    Maliekal TT; Antony ML; Nair A; Paulmurugan R; Karunagaran D
    Oncogene; 2003 Jul; 22(31):4889-97. PubMed ID: 12894231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
    Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the Smad6 and Smad7 genes in hepatocellular carcinoma.
    Kawate S; Ohwada S; Hamada K; Koyama T; Takenoshita S; Morishita Y; Hagiwara K
    Int J Mol Med; 2001 Jul; 8(1):49-52. PubMed ID: 11408948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies.
    Shiohara M; Spirin K; Said JW; Gombart AF; Nakamaki T; Takeuchi S; Hatta Y; Morosetti R; Tasaka T; Seriu T; Bartram C; Miller CW; Tomonaga M; Koeffler HP
    Leukemia; 1996 Dec; 10(12):1897-900. PubMed ID: 8946928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Smad3 gene in hematological malignancies.
    Ikezoe T; Takeuchi S; Arai T; Yuasa Y; Taguchi H
    Int J Hematol; 1998 Dec; 68(4):457-8. PubMed ID: 9885447
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
    Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
    Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of ETV6 in prostate carcinoma.
    Kibel AS; Faith DA; Bova GS; Isaacs WB
    Prostate; 2002 Sep; 52(4):305-10. PubMed ID: 12210491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AML-1 mutations outside the RUNT domain: description of two cases in myeloid malignancies.
    Carnicer MJ; Nomdedéu JF; Lasa A; Bellido M; Aventín A; Baiget M; Sierra J
    Leukemia; 2002 Nov; 16(11):2329-32. PubMed ID: 12399980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.